Dr. Tomas Ganz, Co-founder of ILS, will be inaugurated as the President of the International BioIron Society. His leadership in the BioIron field creates novel insights into iron homeostasis and diseases involving the molecular biology of the iron regulatory hormone hepcidin.

In addition, Mark Westerman, Founder & CEO of ILS will present an update on the development of hepcidin ELISA kits suitable for automation or laboratory use in clinical research and development projects. Visit our poster and meet Drs. Westerman, Ganz, and Nemeth for disucssions of projects and potential collaborative studies.